Beefing up its new gene therapy unit, Catalent inks $18M deal to snap up Novavax facilities - Endpoints News

Beefing up its new gene therapy unit, Catalent inks $18M deal to snap up Novavax facilities  Endpoints News

With an $18 million payment, Paragon is taking over two Novavax sites in Gaithersburg, MD, including more than 100 of the employees already working there.